The November 2008 issue of Drug and Therapeutics Bulletin (DTB) has two articles. The first is a review of ▼Alateris, the first licensed glucosamine (as hydrochloride) available for osteoarthritis. The second article reviews ▼ivabradine, the first of a new class of drugs for stable angina. The issue also contains short corrections for two previous DTB articles: What role for ▼tigecycline in infections? (August 2008) and ▼Retapamulin for impetigo and other  infections (October 2008).